Earlier in April, Pfizer stated that it had supplied a not-for-profit worth for its vaccine for the federal government immunisation programme in India and it stays dedicated to persevering with engagement with the federal government to make the vaccine obtainable in India.
“Pfizer is conscious that entry to vaccines is vital to ending this pandemic. Unfortunately, our vaccine isn’t registered in India though our utility was submitted months in the past.
We are at the moment discussing with the Indian authorities an expedited approval pathway to make our Pfizer-BioNTech vaccine obtainable for use within the nation,” Bourla stated in a mail despatched to Pfizer India staff that he has shared on his linked.in put up.
Pfizer has earlier stated that, in the course of the pandemic section, it’s going to provide the Pfizer-BioNTech COVID-19 mRNA vaccine solely by means of authorities contracts.
“Pfizer remains committed to continuing our engagement with the government towards making the Pfizer and BioNTech vaccine available for use in the government’s immunisation programme in the country,” the corporate had stated in April in electronic mail response to PTI.
The Indian authorities final month allowed emergency use approval of the imported vaccines in India which have been granted emergency approval for restricted use by United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), UK Medicines and Healthcare merchandise Regulatory Agency (UK MHRA), Pharmaceuticals and Medical Device Agency (PMDA) Japan or that are listed in WHO (emergency use itemizing).